E-DRUG Archives (by date)

• Thread Index

March 31, 2003
• [e-drug] WHO Essential Drugs Committee meets this week
  • From: WilbertBannenberg@compuserve.com
• [e-drug] Research for DOT-HAART paper
  • From: Pranish Kantesaria <Pranish@alum.rpi.edu>
• [e-drug] Concept of generic drugs (cont'd)
  • From: Claudia Vacca <cvacag@invima.gov.co>
• [e-drug] Expiry dates of drugs
  • From: <Karin@who.or.id>
• [e-drug] Ethical standards in clinical trials of Antiretroviral drugs
  • From: Jude Ike Nwokike <monkiyke@yahoo.com>
• [e-drug] Reply from Dr Attaran to Dr Srinivas (cont'd)
  • From: Srinivas Tata <tatabuchi@hotmail.com>
March 30, 2003
• [e-drug] Reply from Dr Attaran to Dr Srinivas (cont'd)
  • From: Sarah Sellers <ssellers@jhsph.edu>
March 29, 2003
• [e-drug] Reply from Dr Attaran to Dr Srinivas (cont'd)
  • From: Ram Dixit <ramdixit@yahoo.com>
March 28, 2003
• [e-drug] Reply from Dr Attaran to Dr Srinivas (cont'd)
  • From: Malcolm Bryant <mbryant@healthnet.org>
• [e-drug] Reply from Dr Attaran to Dr Srinivas (cont'd)
  • From: Praveen Bhasa <praveen@som.iitb.ac.in>
• [e-drug] FDA public health advisory on Lindane products
  • From: E-drug <e-drug@healthnet.org>
• [e-drug] Pharmaceutical companies and the third world
  • From: E-drug <e-drug@healthnet.org>
• [e-drug] Reply from Dr Attaran to Dr Srinivas (cont'd)
  • From: Aniruddha Malpani <malpani@vsnl.com>
• [e-drug] Reply from Dr Attaran to Dr Srinivas (cont'd)
  • From: Mohga Kamal Smith <mksmith@oxfam.org.uk>
• [e-drug] Reply from Dr Attaran to Dr Srinivas
  • From: Srinivas Tata <tatabuchi@hotmail.com>
• [e-drug] USA pressure on Australia's affordable drugs scheme
  • From: E-drug <e-drug@healthnet.org>
March 27, 2003
• [e-drug] Concerns about weakening proposals for cheap drugs
  • From: E-drug <E-drug@healthnet.org>
• [e-drug] Drugs from developing countries (cont'd)
  • From: "Jerome.Dumoulin" <Jerome.Dumoulin@upmf-grenoble.fr>
• [e-drug] Concept of generic drugs (cont'd)
  • From: Reinhard Huss <Reinhard.Huss@urz.uni-heidelberg.de>
March 26, 2003
• [e-drug] Drugs from developing countries
  • From: Srinivas Tata <tatabuchi@hotmail.com>
• [e-drug] Patent law (cont'd)
  • From: Murtada Sesay <msesay@unicef.org>
• [e-drug] Patent law (cont'd)
  • From: Srinivas Tata <tatabuchi@hotmail.com>
• [e-drug] Concept of generic drugs (cont'd)
  • From: Srinivas Tata <tatabuchi@hotmail.com>
• [e-drug] Origins of AIDS (cont'd)
  • From: E-drug <e-drug@healthnet.org>
• [e-drug] WHO article on pharmaceutical expenditures (cont'd)
  • From: Andrew Creese <creesea@who.int>
• [e-drug] Drug Bulletin Special Issue on World TB Day
  • From: Azhar Hussain <azhar@thenetwork.org.pk>
March 25, 2003
• [e-drug] Training workshop on writing about medicines for people
  • From: Stein Lyftingsmo <stein@lyftingsmo.no>
• [e-drug] WHO article on pharmaceutical expenditures (cont'd)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• [e-drug] Concept of generic drugs
  • From: Carmen Prez Casas <carmenpcasas@mixmail.com>
• [e-drug] WHO article on comparative pharmaceutical expenditures
  • From: Sunaina Sharma <sunaina@boalthall.berkeley.edu>
• [e-drug] Investors pressure drug firms on pricing (cont'd)
  • From: Patrice Trouiller <pattrouiller@wanadoo.fr>
• [e-drug] Investors pressure drug firms on pricing
  • From: "Ellen 't Hoen" <ellen.t.hoen@paris.msf.org>
March 24, 2003
• [e-drug] Guidelines for labelling and packaging of medicines
  • From: Stein Lyftingsmo <stein@lyftingsmo.no>
• [e-drug] World TB Day 2003
  • From: Rachel Cohen <Rachel.COHEN@newyork.msf.org>
• [e-drug] Tablet-splitting with FDCs, esp. antiretrovirals (cont'd)
  • From: Carolyn Green <greencm@dial.pipex.com>
March 23, 2003
• [e-drug] Tablet-splitting with FDCs, esp. antiretrovirals (cont'd)
  • From: Tim Read <TRead@mshc.org.au>
March 22, 2003
• [e-drug] Aids protests in South Africa
  • From: Valeria Frighi <valeria.frighi@doctors.org.uk>
• [e-drug] Patent law
  • From: E-drug <e-drug@healthnet.org>
March 21, 2003
• [e-drug] Statin prescribing information sought
  • From: Peter Lurie <plurie@citizen.org>
• [e-drug] Tablet-splitting with FDCs (esp. antiretrovirals)
  • From: Julian Meldrum <julian@nam.org.uk>
• [e-drug] Deceptive practices of drug company
  • From: E-drug <e-drug@healthnet.org>
March 19, 2003
• [e-drug] Geneva meeting on global R&D framework, 29 April 2003
  • From: James Love <james.love@cptech.org>
• [e-drug] New Consensus Statement on hypertension treatment
  • From: E-drug <e-drug@healthnet.org>
March 18, 2003
• [e-drug] Dipyrone and agranulocytosis (cont'd)
  • From: Pablo Adolfo Elías <pelias@lanet.com.ar>
• [e-drug] Quality use of medicines indicators
  • From: Libby Roughead <Libby.Roughead@unisa.edu.au>
• [e-drug] Prescription for pain (Le Monde Diplomatique, March 2003)
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] 5th, updated WHO prequalification list
  • From: WilbertBannenberg@compuserve.com
March 17, 2003
• [e-drug] WHO Expert Committee on selection of essential medicines
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] Origins of AIDS (cont'd)
  • From: David Gisselquist <david_gisselquist@yahoo.com>
• [e-drug] Origins of AIDS (cont'd)
  • From: Andy Gray <Graya1@nu.ac.za>
March 15, 2003
• [e-drug] Origin of AIDS (cont'd)
  • From: e-drug@healthnet.org
• [e-drug] Dipyrone and agranulocytosis (cont'd)
  • From: Gaut Gadeholt <gaut@online.no>
• [e-drug] WHO and training (con't): Search engine tips
  • From: Libby Levison <libby@theplateau.com>
March 14, 2003
• [e-drug] Dipyrone and agranulocytosis
  • From: E-drug <e-drug@healthnet.org>
March 13, 2003
• [e-drug] Origin of AIDS (cont'd)
  • From: Beverley Snell <bev@burnet.edu.au>
• [e-drug] Thank you for supporting a ban on DTCA in NZ
  • From: Peter R Mansfield <peter@healthyskepticism.org>
March 12, 2003
• [e-drug] New HIV & AIDS e-mail newsletter
  • From: Julian Meldrum <julian@nam.org.uk>
• [e-drug] Correct use of antiretrovirals (cont'd)
  • From: Daniel Seyoum <dws@usp.org>
• [e-drug] Correct use of antiretrovirals (cont'd)
  • From: Mary Ojoo <mojoo@gerties.org>
• [e-drug] Origins of AIDS (cont'd)
  • From: E-drug <e-drug@healthnet.org>
March 11, 2003
• [e-drug] Free Educational Malaria CD-ROMs
  • From: Graham.Icke@health.wa.gov.au
• [e-drug] Correct use of antiretrovirals (cont'd)
  • From: Andy Gray <Graya1@nu.ac.za>
• [e-drug] Saline Solution (0.9%) versus Ringer's lactate (cont'd)
  • From: "M. Haniki Nik M" <haniki@usm.my>
• [e-drug] Saline Solution (0.9%) versus Ringer's lactate (cont'd)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• [e-drug] Drug utilization review write up (cont'd)
  • From: Jonathan Dartnell <jdartnell@tg.com.au>
March 10, 2003
• [e-drug] Saline Solution (0.9%) versus Ringer's lactate
  • From: Sergio Palacio <insumos@minsa.org.ni>
• [e-drug] The most cost effective way to improve health this year?
  • From: Peter Mansfield <peter@healthyskepticism.org>
• [e-drug] Water purifying in developing countries
  • From: E-drug <e-drug@healthnet.org>
• [e-drug] Drug prices in Sri Lanka
  • From: Valeria Frighi <valeria.frighi@dtu.ox.ac.uk>
March 09, 2003
• [e-drug] Workshop on pharmacogenetics of drug metabolism
  • From: Collen Masimirembwa <Collen.Masimirembwa@astrazeneca.com>
• [e-drug] Re: Origins of AIDS (cont'd)
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] Origins of AIDS (cont'd)
  • From: Beverley Snell <bev@burnet.edu.au>
• [e-drug] Shortages of medicines
  • From: Stein Lyftingsmo <stein@lyftingsmo.no>
March 08, 2003
• [e-drug] FTC case against BMS for blocking generic entry
  • From: James Love <james.love@cptech.org>
• [e-drug] South Africa stalls again on access to HIV drugs
  • From: e-drug@healthnet.org
• [e-drug] How a statin might destroy a drug company
  • From: e-drug@healthnet.org
• [e-drug] Please help ban drug ads to the public
  • From: Peter Mansfield <peter@healthyskepticism.org>
March 07, 2003
• [e-drug] Table of contents for PhRMA 301 submission
  • From: James Love <james.love@cptech.org>
• [e-drug] Generic ARV production and sales
  • From: James Love <james.love@cptech.org>
• [e-drug] Correct use of antiretrovirals
  • From: E-drug <e-drug@healthnet.org>
• [e-drug] WHO and training (cont'd)
  • From: Kae Ting Trouilloud <kaecherie@yahoo.co.uk>
• [e-drug] Drug utilization review write up
  • From: Wong Wai See <ycwong@brunet.bn>
• [e-drug] Pharmaceutical inventory control software
  • From: mSupply <info@msupply.org.nz>
• [e-drug] Generic Prescribing to enhance access to medicines
  • From: Azhar Hussain <azhar@thenetwork.org.pk>
March 06, 2003
• [e-drug] Chinese-developed malarial drug Artekin
  • From: Leela McCullough <leela@healthnet.org>
• [e-drug] US Abortion Politics and Global Fund
  • From: Leela McCullough <leela@healthnet.org>
• [e-drug] Literature on PTC efficiency
  • From: "S. Lerkiatbundit" <lsanguan@makok.pharmacy.psu.ac.th>
March 05, 2003
• [e-drug] World's first-ever anti-smoking treaty
  • From: e-drug@healthnet.org
• [e-drug] WHO Indicators (cont'd)
  • From: Kathy Holloway <hollowayk@who.int>
• [e-drug] Drug trials
  • From: E-drug <e-drug@healthnet.org>
• [e-drug] Blockbuster drugs
  • From: E-drug <e-drug@healthnet.org>
• [e-drug] Origins of AIDS (cont'd)
  • From: George Schmid <schmidg@who.int>
March 04, 2003
• [e-drug] WHO, UNAIDS and UNICEF meet with generics industry
  • From: Hans Hogerzeil <hogerzeilh@who.int>
March 03, 2003
• [e-drug] Request to review excerpt PhD thesis
  • From: Donna van Bogaert <ljfvanbo@lantic.net>
• [e-drug] RUD course - French (cont'd)
  • From: Kathy Holloway <hollowayk@who.int>
• [e-drug] WHO EML Committee agenda 31.03 - 03.04 2003 (cont'd)
  • From: Robin Gray <grayr@who.int>
March 02, 2003
• [e-drug] WHO Medicnes bookshelf (cont'd)
  • From: Richard Laing <richardl@bu.edu>
March 01, 2003
• [e-drug] Drugs with narrow therapeutic index (cont'd)
  • From: Perla Mordujovich <pmordujo@netverk.com.ar>